Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders. - Wikidata - wikimedia - TriplyDB

Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders.

Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders.

http://www.wikidata.org/entity/Q30823738

about

Protein biomarkers of mood disorders.Matrix metalloproteinase activity stimulates N-cadherin shedding and the soluble N-cadherin ectodomain promotes classical microglial activation Update on bipolar disorder biomarker candidates.Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry.Plasma GDF15 level is elevated in psychosis and inversely correlated with severity.Proteomic Differences in Blood Plasma Associated with Antidepressant Treatment Response.hsa_circRNA_103636: potential novel diagnostic and therapeutic biomarker in Major depressive disorder.Further Evidence of Accelerated Aging in Bipolar Disorder: Focus on GDF-15.Proteomics for blood biomarker exploration of severe mental illness: pitfalls of the past and potential for the future

P2860

Q30395834-517F3544-1D3D-41EA-897F-C3E33C669321 Q37708436-B6D75826-32BC-43CC-9A05-1E9C13E0BE4E Q38803583-8815C986-3C59-4DD6-B9D9-194517010EAD Q40058836-FABC5394-0B7E-4012-BA0C-91F070AF1847 Q41367462-355B6765-FCEA-4522-8F2C-8FA0989B06AE Q41605632-FA7025A6-1C2B-4CC6-8DBD-5E232A93AFF3 Q48049122-33C8B1DA-D606-49BC-B690-791F77359DAC Q53420692-2BCC2936-B096-43FF-98ED-6746E98F56E2 Q57169146-184F3759-8E23-4B0D-8764-358197251818

P2860

Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders.

http://www.wikidata.org/entity/Q30823738

description

2015 nî lūn-bûn

@nan

2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Feasibility of investigating d ...... development in mood disorders.

@ast

Feasibility of investigating d ...... development in mood disorders.

@en

type

label

Feasibility of investigating d ...... development in mood disorders.

@ast

Feasibility of investigating d ...... development in mood disorders.

@en

prefLabel

Feasibility of investigating d ...... development in mood disorders.

@ast

Feasibility of investigating d ...... development in mood disorders.

@en

P1433

Q30823738-987D3A72-8E55-47CA-858E-FACA6C051A4A

P1476

Q30823738-3E16F04C-1E40-483C-B92B-90BC44DD14B0

P2093

Q30823738-07F5E882-6699-4FF4-8651-C84E7A42068C

Q30823738-0F410422-19B5-46E2-A126-93422EAB4214

Q30823738-471B1175-98CD-425F-9A7A-A7B23B6411F7

Q30823738-54D202EC-2166-4861-92FE-83792787D549

Q30823738-6446FAA5-DDC3-41FA-A058-207209DADF36

Q30823738-F0A60482-82CC-4E68-B871-73750C047C2C

Q30823738-FE3F3158-381B-4DA7-8862-39D9D0AD13B4

Q30823738-FF15C9C1-D5DD-4ED5-92A0-FCC72E494426

P2860

Q30823738-012D2899-649C-453B-92A8-BB51C5600B61

Q30823738-052909C6-D5FB-46FF-8845-FE23B0A48000

Q30823738-09B69FE7-FD37-43C8-B022-A806AF2B3DD3

Q30823738-0DBC3792-1FBF-4BAC-AB72-4581EE27A42F

Q30823738-0E7FE82C-FAAF-4749-AF6C-3F5E7AC92FE1

Q30823738-120EA5BA-FF49-44E9-8B03-EAE8DD11A36A

Q30823738-132D731C-E444-4DD1-AC7B-64D38A45ACF6

Q30823738-1B217B1C-D601-4EE4-8955-25B5AF9F0EC4

Q30823738-1F1EF1C0-F52D-41AE-A275-A60985F1F5A1

Q30823738-2B8E2550-5A68-4116-AA7F-BA14549EBC71

P2888

Q30823738-273CB0E0-AF87-44D5-9DA9-DC81A2711CE4

P304

Q30823738-149E88DA-6CDE-42AB-A984-9600119AD18C

P31

Q30823738-5B3E5595-6157-4F0B-860C-E73AE23CA85A

P356

Q30823738-AEE6B62E-BD79-4AAA-A9B1-3E87B78AD19D

P478

Q30823738-9AB0D804-BC15-419A-A29A-008A9BC88389

P50

Q30823738-4790D64B-7AE4-465E-986D-92A3DCE6254B

Q30823738-7B501064-CC13-435C-BFCF-266727E66442

P577

Q30823738-72B18156-4100-46FD-B5E2-8757B101CA23

P5875

Q30823738-B8B37ED5-172A-45B9-A93A-41D9F6D8FFE8

P6179

Q30823738-ABDC9AB0-590D-4341-9F21-D669004CDAE2

P698

Q30823738-7B1F65B6-7A1F-4DCD-80A6-89B96F3328B6

P921

Q30823738-7F60AB55-BE9F-4074-96CA-DA53EDC8DB08

P932

Q30823738-D8A6C4C9-57F3-4E5E-9E5E-EC587137D511

P356

P1433

Translational Psychiatry

P1476

Feasibility of investigating d ...... development in mood disorders

@en

P2093

B A Palmer

http://www.w3.org/2001/XMLSchema#string

D S Choi

http://www.w3.org/2001/XMLSchema#string

G D Jenkins

http://www.w3.org/2001/XMLSchema#string

J M Biernacka

http://www.w3.org/2001/XMLSchema#string

M A Frye

http://www.w3.org/2001/XMLSchema#string

M Nassan

http://www.w3.org/2001/XMLSchema#string

S E Feeder

http://www.w3.org/2001/XMLSchema#string

S Kung

http://www.w3.org/2001/XMLSchema#string

P2860

A gene atlas of the mouse and human protein-encoding transcriptomes

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II

A rating scale for mania: reliability, validity and sensitivity

Evaluation of plasma proteomic data for Alzheimer disease state classification and for the prediction of progression from mild cognitive impairment to Alzheimer disease.

Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections.

Multiplexed microbead immunoassays by flow cytometry for molecular profiling: Basic concepts and proteomics applications.

A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers

Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Low levels of transthyretin in the CSF of depressed patients.

P2888

P304

e689

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/TP.2015.185

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Susannah J. Tye

P577

2015-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

286413331

http://www.w3.org/2001/XMLSchema#string

P6179

1006193642

http://www.w3.org/2001/XMLSchema#string

P698

26645624

http://www.w3.org/2001/XMLSchema#string

P921

P932

5068585

http://www.w3.org/2001/XMLSchema#string